We’re not 2D. We’re not 3D.
We’re HUMAN.
Tumor-Specific In Vitro 3D Models for Drug Development.
We believe
That to understand how therapeutic agents behave in a patient, we need to use models that mimic actual human tissue. zPREDICTA’s technology is close as it gets.
Recapitulation of Human Tissue Environment
Enabling Accurate Testing of Anticancer Agents


zPREDICTA’s comprehensive 3D culture approach integrates organ-specific cellular and extracellular elements to preserve the critical interactions between a tumor and its surroundings.
-
Accurate
Data demonstrate high correlation of zPREDICTA’s platform with clinical outcomes
-
Reproducible
Robust, replicable data to facilitate informed drug development decisions.
-
Customizable
Compatible with multiple tissue/cell types, classes of therapeutic agents, and readouts.
Human tissues are not flat





zPREDICTA’s organ-specific disease models provide 3D reconstruction of human tissues accurately representing each disease state and mimicking drug response.
-
Efficacy screening of anticancer compounds
-
Evaluation of mechanisms of drug resistance
-
Rescue of failed drug candidates
Unique Advantages
zPREDICTA’s next-generation technology is based on extensive research of the human tumor microenvironment.


Physiological
Accurate reconstruction of the organ-specific 3D tissue microenvironment enabling evaluation of therapeutic agents under conditions mimicking human physiology.


Replicates Tissue Heterogeneity
Long-term maintenance of primary human cells, organoids, and cell lines under the native conditions of human disease.


Clinically Relevant
Reliable prediction of clinical outcomes based on accurate reconstruction of cellular and extracellular compartments of human tissues.